Cargando…
Building a global immune system
The COVID-19 pandemic exposed global vulnerabilities to emerging infectious diseases, heralded by earlier outbreaks, that did not result in appropriate investments in surveillance, international collaboration, and response. We propose specific steps that should be taken to reduce future risks to pub...
Autores principales: | Lipkin, W. I., Briese, T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196843/ https://www.ncbi.nlm.nih.gov/pubmed/35201958 http://dx.doi.org/10.1080/21645515.2022.2036069 |
Ejemplares similares
-
Opportunities and challenges for commercializing microarray patches for vaccination from a MAP developer’s perspective
por: Forster, Angus, et al.
Publicado: (2022) -
Multi-valent pneumococcal conjugate vaccine for global health: From problem to platform to production
por: Datta, Anup, et al.
Publicado: (2022) -
RSV disease in infants and young children: Can we see a brighter future?
por: Baraldi, Eugenio, et al.
Publicado: (2022) -
2021 ISV Annual Virtual Congress
por: Cox, Manon
Publicado: (2022) -
Meet the fellows: Everything about ISV
por: Doolan, Denise, et al.
Publicado: (2022)